REDUCED CERVICAL CANCER SCREENING FREQUENCY IN HUMAN PAPILLOMAVIRUS VACCINATED, HIV-INFECTED WOMEN: A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Cohen, Jamie [1 ]
Menzies, Nicolas A. [2 ]
Kim, Jane J. [3 ]
机构：
[1] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA
[3] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
来源：
MEDICAL DECISION MAKING | 2020年 / 40卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
PS 2-14
引用
收藏
页码：E85 / E85
页数：1
相关论文
共 50 条
  • [1] The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women
    Goldie, SJ
    Weinstein, MC
    Kuntz, KM
    Freedberg, KA
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (02) : 97 - +
  • [2] Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis
    Accetta, Gabriele
    Biggeri, Annibale
    Carreras, Giulia
    Lippi, Giuseppe
    Carozzi, Francesca Maria
    Confortini, Massimo
    Zappa, Marco
    Paci, Eugenio
    [J]. JOURNAL OF MEDICAL SCREENING, 2010, 17 (04) : 181 - 189
  • [3] Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand
    Sharma, M.
    Ortendahl, J.
    van der Ham, E.
    Sy, S.
    Kim, J. J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (02) : 166 - 176
  • [4] CARDIOVASCULAR DISEASE SCREENING IN HIV-INFECTED PATIENTS - A COST-EFFECTIVENESS ANALYSIS
    Nolte, J. E. H.
    Neumann, T.
    Neumann, A.
    Manne, J.
    Mostardt, S.
    Abbara, S.
    Brady, T. J.
    Hoffmann, U.
    Gazelle, G. S.
    Wasem, J.
    Goehler, A.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A8 - A8
  • [5] Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus
    Goldie, SJ
    Freedberg, KA
    Weinstein, MC
    Wright, TC
    Kuntz, KM
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 111 (02): : 140 - 149
  • [6] Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis
    Naber, Steffie K.
    Matthijsse, Suzette M.
    Rozemeijer, Kirsten
    Penning, Corine
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    [J]. PLOS ONE, 2016, 11 (01):
  • [7] Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
    Burger, E. A.
    Ortendahl, J. D.
    Sy, S.
    Kristiansen, I. S.
    Kim, J. J.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (09) : 1571 - 1578
  • [8] Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
    E A Burger
    J D Ortendahl
    S Sy
    I S Kristiansen
    J J Kim
    [J]. British Journal of Cancer, 2012, 106 : 1571 - 1578
  • [9] Switching clinic-based cervical cancer screening programs to human papillomavirus self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women
    Pedersen, Kine
    Portnoy, Allison
    Sy, Stephen
    Hansen, Bo T.
    Trope, Ameli
    Kim, Jane J.
    Burger, Emily A.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (03) : 491 - 501
  • [10] Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men
    Nolte, Julia E. H.
    Neumann, Till
    Manne, Jennifer M.
    Lo, Janet
    Neumann, Anja
    Mostardt, Sarah
    Abbara, Suhny
    Hoffmann, Udo
    Brady, Thomas J.
    Wasem, Juergen
    Grinspoon, Steven K.
    Gazelle, G. Scott
    Goehler, Alexander
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (08) : 972 - 979
12345